Navigation Links
Yvonne Verburgt Joins the Avrio Executive Team as Vice President of Business Development and Marketing

IRVINE, Calif., March 3 /PRNewswire/ -- Avrio Biopharmaceuticals, LLC, a premier contract development and manufacturing organization, announced the addition of Yvonne Verburgt as Vice President of Business Development and Marketing. Yvonne brings over 28 years of pharmaceutical industry experience to the company and to the clients it serves.  

"We are very excited to bring Yvonne on board," said Assad J. Kazeminy, President and Founder of Avrio Biopharmaceuticals. "Yvonne brings years of experience with a remarkable track record to our executive team. She is an innovative and seasoned scientific sales leader and I look forward to the great contributions she will bring to the company and our clients."

Yvonne's most recent venture as the head of Business Development at Pharmatek Laboratories, Inc. involved successfully leading the sales team to help expand business of pharmaceutical chemistry development services. Her previous work experience includes serving as the Director of North American Sales for Patheon, Inc., and holding similar sales and management roles for companies including Oread, Inc., Becton Dickinson, Behring Diagnostics, Abbott Laboratories, and Johnson & Johnson. 

"Yvonne's extensive history in science and sales makes her an ideal addition to our executive team," said Aryo A. Nikopour, Vice President of Scientific and Technical Services. "She brings an impressive depth of knowledge and leadership skills and will be instrumental in building our customer-centric business."

You can learn more about Avrio and the executive team at the upcoming 2010 PDA Annual Meeting, booth 714.

About Avrio Biopharmaceuticals, LLC

Avrio Biopharma, an affiliate of Irvine Pharmaceutical Services, is a premier contract development and manufacturing organization providing support to the pharmaceutical, biopharmaceutical, and medical device industries. Avrio, along with its Irvine affiliate, offers full cGMP product development support, specializing in preformulation/formulation, analytical development, process validation, scale-up studies, packaging and labeling, stability storage and complete analytical CMC testing. Learn more at or call 866-98-AVRIO (866-982-8746).

SOURCE Avrio Biopharmaceuticals, LLC

Back to top



SOURCE Avrio Biopharmaceuticals, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Lumetra PSO Joins Forces With iSOFT Solutions
2. Ritter Pharmaceuticals Joins NIH Conference Discussions on Lactose Intolerance and Associated Health Risks
3. Top Bristol-Myers Squibb Executive Joins Patton Boggs
4. Government Relations CEO Joins MedeFile Advisory Board
5. Eamonn Hobbs Joins the Board of Directors at Cappella
6. Former Air Force Surgeon General Joins Integrated Medical Systems Advisory Board
7. Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
8. Steven Leventer Joins PharmaNet Development Group as Vice President, Clinical Research Neuroscience
9. New Life Agency, Inc. Joins Forces With The Diamond Institute and Walgreens Specialty Pharmacy to Introduce the Nations First In Vitro Fertilization Insurance Program
10. CooperVision Adds Global Professional Relations Role; Richard Clompus Joins Company as Vice President
11. Professor Riccardo Lencioni Joins Delcath Systems Scientific Advisory Board
Post Your Comments:
(Date:10/2/2017)... Labs announces the European launch of their new low volume, high ... in Cambridge, U.K on October 4th. The ... with unprecedented speed and sensitivity while using far less sample volume ... ... ...
(Date:9/27/2017)...  Commended for their devotion to personalized service, SMP Pharmacy ... one in the South Florida Business Journal,s 50 Fastest-Growing Companies, ... list, the national specialty pharmacy has found its niche.  To ... soon be honored by SFBJ as the 2017 Power Leader ... to receive his award in October, Bardisa said of the ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... , ... Ellevate Network, the leading network for professional women, brought together some ... at their inaugural Summit in New York City in June. The event was livestreamed ... over 3 million. To watch the Mobilize Women video, click here . ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
(Date:10/13/2017)... ... 13, 2017 , ... “America On The Brink”: the Christian history of the ... is the creation of published author, William Nowers. Captain Nowers and his wife, ... he spent thirty years in the Navy. Following his career as a naval ...
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
Breaking Medicine News(10 mins):